The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21(Cip1) and p27(Kip1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells (Q34528939)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21(Cip1) and p27(Kip1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells |
scientific article |
Statements
1 reference
The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21(Cip1) and p27(Kip1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells (English)
1 reference
Thomas C Chen
1 reference
Pia Wadsten
1 reference
Susan Su
1 reference
Neal Rawlinson
1 reference
Florence M Hofman
1 reference
Colin K Hill
1 reference
Axel H Schönthal
1 reference
1 May 2002
1 reference
1 reference
1
1 reference
3
1 reference
268-276
1 reference
Identifiers
1 reference
1 reference